Cegedim Sa · EURONEXT:ALCGM

Cegedim Sa — H1 2019 Earnings Presentation

42 slides from Cegedim Sa's earnings presentation, September 2019

  1. Slide 1: First-Half Results 2019

  2. Slide 2: Forward-looking statements

    This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that may not prove to be accurate. By their nature,

  3. Slide 3: Business

    Business Pierre Marucchi Vv) oi =) V) Lu ~

  4. Slide 4: Cegedim at a glance

    Bi cegedim Cegedim at a glance Cegedim: Data, Digital and SaaS Specialist in Healthcare & other industries 4,782 employees in +10 countries 3 business groups: + Health Insurance, HR & e-services + Healthcare Professionals + Corporate & Others

  5. Slide 5: Cegedim at a glance

    fw cegedim Cegedim at a glance CGM LISTED IN PARIS SHAREHOLDERS FCB 53% FREE FLOAT 46% CEGEDIM 1% August 31, 20/9

  6. Slide 6: Unique Healthcare footprint

    Unique Healthcare footprint 6

  7. Slide 7: Cegedim: Business divisions

    Cegedim: 2 Business divisions 7

  8. Slide 8: HY 19 Financial Overview

    Ba cegedim HY 19 Financial Overview in€m CEGEDIM GROUP HEALTH INSURANCE, HEALTHCARE HR & E-SERVICES PROFESSIONALS +8.0% +8.7% +7.1% REVENUE €245.8ml] 64%141 €162.5m]ico%r+1 €81.6m | 5 9%1-41 Recuring Operatin +€0.7m €(2.7)m +€3.8m ee P 2 €12.6m +5.8% el 0.7m (20.3)% €2.9m mn come Recuring Operating

  9. Slide 9: Business reinforced by bolt-on acquisitions (H1-19)

    Business reinforced by bolt-on acquisitions (H1-19) 9

  10. Slide 10: Business reinforced by bolt-on acquisitions (post H1-19)

    Business reinforced by bolt-on acquisitions (post H1-19) 10

  11. Slide 11: Focus on European activities

    Focus on European activities 11

  12. Slide 12: Strong innovation capacity

    Strong innovation capacity 12

  13. Slide 13: Strong BPO trend

    Strong BPO trend wn a =) wn Lu [a4 en @ €21.5m 5%* 6%* 7%* 8%* 9%* HY-2015, HY-2016 HY-2017 HY-2018 JUN.2015 DEC. 2015 DEC. 2016 = DEC. 2017_—s« DEC. 2018 * as of % of total consolidated Group Revenue 13

  14. Slide 14: Docavenue Teleconsultation: Key achievements

    Docavenue Teleconsultation: Key achievements 14

  15. Slide 15: Conclusion: Cegedim's 3 pillars

    Conclusion: Cegedim’s 3 pillars 15

  16. Slide 16: Finance

    Finance HY 2019 Results Vv) oi =) V) Lu ~

  17. Slide 17: IFRS 16 Application

    IFRS 16 Application Applied since January 1st, 2019 • Applied to leases involving fixed payments, mostly related to rents • Financial statements not restated as of December 31 and June 30, 2018, in accordance with the standard • Negligible impact on net profit (loss) • Impact on EBITDA: +€7.9 millio

  18. Slide 18: Key Operating Performance

    Key Operating Performance 18

  19. Slide 19: HY-2019 Revenue Overview

    HY-2019 Revenue Overview © cegedim 2019 19

  20. Slide 20: Strong BPO trend

    Ba cegedim Strong BPO trend BPO REVENUE 2a a = — —- HY-2015, HY-2016 HY-2017 HY-2018 HY-2019 * as of % of total consolidated Group Revenue 20

  21. Slide 21: L-f-l HY-19 Revenue growth by business group

    L-f-l HY-19 Revenue growth by business group 21

  22. Slide 22: HY 2019 EBITDA Trend

    me cegedim HY 2019 EBITDA Trend €45.5m MARGIN 18.5% €33.3m MARGIN 14.6% +8.7% — & ees ran) RESTATED IAST REVENUE PAYROLL EXTERNAL PURCHASES OTHERS IFRS 16 €37.6m COSTS EXPENSES USED FIRST 15.3% APPLICATION ciel HY 2018 HY 2019 22

  23. Slide 23: Health Insurance HR & E-Services Division

    Health Insurance HR & E-Services Division © cegedim 2019 23

  24. Slide 24: Healthcare Professionals Division

    Healthcare Professionals Division © cegedim 2019 24

  25. Slide 25: HY 19: From EBITDA to Net Earnings

    HY 19 : From EBITDA to Net Earnings 25

  26. Slide 26: HY 2019 Financial Performance

    HY 2019 Financial Performance In € million HY 18 HY 19 % change €245.8m REVENUE EBITDA 227.6 33.3 245.8 45.5 +8.0% +36.5% REVENUE Margin IFRS 16 14.6% 18.5% +386bps D&A (21.4) (32.8) +53.6% RECURRING OPERATING INCOME 11.9 12.6 +5.8% €45.5m Margin 5.2% 5.1% (10)bps Other non-recurring operating incom

  27. Slide 27: FCF from operations

    FCF from operations €(35.8)m In € million Cash flow before taxes and interests HY 18 28.3 HY 19 43.1 FCF from operations Change in working capital requirement +11.5 (47.6) ! Corporate tax paid (0.7) (0.5) €(59)m Net cash flow from operating activities 39.1 (4.9) Negative impact Acquisition of intang

  28. Slide 28: Change in Net Financial Debt

    Change in Net Financial Debt Incorporating for the first time the effects of the application of IFRS 16 Leases ! DEC. DEC.2018 2018 Jun. 2019 JUN. Negative Impact: €14.9 million from factoring cancellations and €31.3 million from the negative trend in advances paid by clients at the health insurance

  29. Slide 29: HY 2019 Balance Sheet: Sound Financial Structure

    HY 2019 Balance Sheet Sound Financial Structure In € million Dec. 18 Jun. 19 As a liability: recognition of a lease liability (€67.5 million - ASSETS 1 €53.3 million non current portion and €14.2 million current portion-) , measured at the discounted present value of future Goodwill 173.0 180.5 paym

  30. Slide 30: Outlook for FY 2019

    Finance Outlook for FY 2019 Vv) oi =) V) Lu ~

  31. Slide 31: Pulse contribution to P&L and BS

    Pulse contribution to P&L and BS Contribution to consolidated Group: In € million H1-18 H2-18 FY-18 HY 19 REVENUE 5.8 5.5 11.3 5.6 EBITDA(1) (1.8) (1.4) (3.2) 0.0 DAP (2.3) (2.4) (4.7) (3.3) RECURRING OPERATING INCOME (4.1) (3.8) (7.9) (3.3) Operating income (7.0) (3.1) (10.1) (18.2) R&D CAPITALIZED

  32. Slide 32: Potential Impact of Brexit

    Potential Impact of Brexit 32

  33. Slide 33: Outlook: Raised for 2019

    Ba cegedim Outlook: Raised for 2019 2019 ONWARDS: ACCELERATE fence ANDGROW (Sweyy MAINTAINING STEADY, SUSTAINABLE, PROFITABLE GROWTH MOMENTUM FY 19 REVENUE FY 19 EBITDA These projections are publicy disclosed on September 19, 2019. The fact that Cegedim includes these projections in this presen- tat

  34. Slide 34: Annexes

    Annexes HY 2019 Results Vv) oi =) V) Lu ~

  35. Slide 35: Recurring operating income (REBIT) and EBITDA

    Recurring operating income (REBIT) and EBITDA in € million HY 18 HY 19 Reported Reported OPERATING INCOME (a) 2.3 (3.6) Other non-recurring operating income and expenses (b) (9.6) (13.8) Amortization of goodwill (c) 0.0 (2.5) RECURRING OPERATING INCOME (REBIT) (d= a-b-c) 11.9 12.6 Depreciation and a

  36. Slide 36: H1-2019 Revenue

    H1-2019 Revenue In € thousands Division 1 Division 2 Division 3 Group 2018 REVENUE (a) 149,537 76,162 1,936 227,634 Impact of disposals 0 0 0 0 2018 Revenue before impact of disposals 149,537 76,162 1,936 227,634 Currency impact 3 525 0 528 2018 Revenue at 2019 exchange rate (b) 149,540 76,687 1,936

  37. Slide 37: HY 2019 P&L – IFRS 16 Bridge

    HY 2019 P&L – IFRS 16 BRIDGE In € million HY 18 HY 19 % HY 19 IFRS 16 Reported IAS 17 change Reported Impact REVENUE 227.6 245.8 +8.0% 245.8 - EBITDA 33.3 37.6 +12.9% 45.5 +7.9 Margin 14.6% 15.3% +67 bps 18.5% D&A (21.4) (25.1) +17.4% (32.8) (7.8) RECURRING OPERATING INCOME 11.9 12.5 +5.0% 12.6 +0.1

  38. Slide 38: HY 2019 P&L – IFRS 16 Bridge: Health insurance, HR and e-services

    HY 2019 P&L – IFRS 16 BRIDGE in € million Health insurance, HR and e-services HY 18 HY 19 % HY 19 IFRS 16 Reported IAS 17 change Reported Impact REVENUE 149.5 162.5 +8.7% 162.5 - EBITDA 24.2 23.2 (4.1)% 26.7 +3.4 Margin 16.2% 14.3% -190 bps 16.4% D&A (10.8) (12.6) +16.9% (16.0) (3.3) RECURRING OPERA

  39. Slide 39: HY 2019 P&L – IFRS 16 Bridge: Healthcare professionals

    HY 2019 P&L – IFRS 16 BRIDGE in € million Healthcare professionals HY 18 HY 19 % HY 19 IFRS 16 Reported IAS 17 change Reported Impact REVENUE 76.2 81.6 +7.1% 81.6 - EBITDA 6.9 12.6 82.1% 14.9 +2.3 Margin 9.1% 15.4% +634 bps 18.3% D&A (7.8) (9.7) +24.1% (11.9) (2.3) RECURRING OPERATING INCOME (0.9) 2

  40. Slide 40: HY 2019 P&L – IFRS 16 Bridge: Corporate and others

    HY 2019 P&L – IFRS 16 BRIDGE in € million Corporate and others HY 18 HY 19 % HY 19 IFRS 16 Reported IAS 17 change Reported Impact REVENUE 1.9 1.7 (10.9)% 1.7 - EBITDA 2.2 1.8 (16.9)% 3.9 +2.1 Margin 113.7% 106.1% n.m. 226.9% D&A (2.8) (2.8) +0.1% (4.9) (2.1) RECURRING OPERATING INCOME (0.6) (0.9) +6

  41. Slide 41: HY 2019 Balance Sheet – IFRS 16 Bridge

    HY 2019 Balance Sheet – IFRS 16 BRIDGE In € million Dec. 18 Jun.19 %Change Jun. 19 IFRS 16 Reported IAS 17 IFRS 16 Impact ASSETS In €m Goodwill 173.0 180.5 +4.3% 180.5 - Intangible assets 156.7 151.3 (3.4)% 151.3 - Tangible assets 33.4 33.3 (0.2)% 100.2 +66.9 Financial assets 21.0 21.4 +2.0% 21.4 -

  42. Slide 42: Thank you for your attention

    Thank you for your attention Jan Eryk Umiastowski Chief Investment Officer – Head of Investor Relations janeryk.umiastowski@cegedim.com Tel: 00 33 1 49 09 33 36 – Mob: 00 33 6 73 25 96 34 Design: Group Communication Service

Cegedim — H1 2019 Earnings Presentation on 6ix